Complete Genomics Will be Acquired by Shenzhen; Holders Will Get $3.15


27% profits every 20 days?

This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.


Complete Genomics (Nasdaq: GNOM) and BGI-Shenzhen ("BGI"), a leadinginternational genomics company based in Shenzhen, China, today announced thatthey have entered into a definitive merger agreement. Through this agreement,a wholly-owned U.S. subsidiary of BGI will launch a tender offer to purchaseall outstanding shares of common stock of Complete for $3.15 per share incash, without interest. This price represents approximately a 54% premium tothe $2.04 closing price per share of Complete common stock on June 4, 2012,the last trading day prior to Complete's announcement that it was undertakingan evaluation of strategic alternatives to secure the financial resourcesneeded for continued commercialization of its technology.

27% profits every 20 days?

This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.


ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Posted In: NewsFDAM&A